575 related articles for article (PubMed ID: 26347709)
1. The Role of Astrocytes in Multiple Sclerosis Progression.
Correale J; Farez MF
Front Neurol; 2015; 6():180. PubMed ID: 26347709
[TBL] [Abstract][Full Text] [Related]
2. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
3. The role of glial cells in multiple sclerosis disease progression.
Healy LM; Stratton JA; Kuhlmann T; Antel J
Nat Rev Neurol; 2022 Apr; 18(4):237-248. PubMed ID: 35190704
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of glia repair and remyelination in antibody-mediated demyelination models of multiple sclerosis and neuromyelitis optica.
Liu Y; Given KS; Owens GP; Macklin WB; Bennett JL
Glia; 2018 Dec; 66(12):2575-2588. PubMed ID: 30240044
[TBL] [Abstract][Full Text] [Related]
5. How factors secreted from astrocytes impact myelin repair.
Moore CS; Abdullah SL; Brown A; Arulpragasam A; Crocker SJ
J Neurosci Res; 2011 Jan; 89(1):13-21. PubMed ID: 20857501
[TBL] [Abstract][Full Text] [Related]
6. Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
Touil H; Kobert A; Lebeurrier N; Rieger A; Saikali P; Lambert C; Fawaz L; Moore CS; Prat A; Gommerman J; Antel JP; Itoyama Y; Nakashima I; Bar-Or A;
J Neuroinflammation; 2018 Apr; 15(1):114. PubMed ID: 29673365
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis.
Farez MF; Correale J
J Neurol Sci; 2016 Feb; 361():60-5. PubMed ID: 26810518
[TBL] [Abstract][Full Text] [Related]
8. The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics.
Barmpagiannos K; Theotokis P; Petratos S; Pagnin M; Einstein O; Kesidou E; Boziki M; Artemiadis A; Bakirtzis C; Grigoriadis N
Healthcare (Basel); 2023 May; 11(11):. PubMed ID: 37297725
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies to target CNS pathophysiology in multiple sclerosis.
Oh J; Bar-Or A
Nat Rev Neurol; 2022 Aug; 18(8):466-475. PubMed ID: 35697862
[TBL] [Abstract][Full Text] [Related]
10. Early glial responses in murine models of multiple sclerosis.
Ayers MM; Hazelwood LJ; Catmull DV; Wang D; McKormack Q; Bernard CC; Orian JM
Neurochem Int; 2004; 45(2-3):409-19. PubMed ID: 15145555
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis.
Correale J; Marrodan M; Ysrraelit MC
Biomedicines; 2019 Feb; 7(1):. PubMed ID: 30791637
[TBL] [Abstract][Full Text] [Related]
12. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of tissue injury in MS lesions.
Trapp BD; Bö L; Mörk S; Chang A
J Neuroimmunol; 1999 Jul; 98(1):49-56. PubMed ID: 10426362
[TBL] [Abstract][Full Text] [Related]
14. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.
Lombardi M; Parolisi R; Scaroni F; Bonfanti E; Gualerzi A; Gabrielli M; Kerlero de Rosbo N; Uccelli A; Giussani P; Viani P; Garlanda C; Abbracchio MP; Chaabane L; Buffo A; Fumagalli M; Verderio C
Acta Neuropathol; 2019 Dec; 138(6):987-1012. PubMed ID: 31363836
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Savarin C; Hinton DR; Valentin-Torres A; Chen Z; Trapp BD; Bergmann CC; Stohlman SA
J Neuroinflammation; 2015 Apr; 12():79. PubMed ID: 25896970
[TBL] [Abstract][Full Text] [Related]
16. Altered astrocytic function in experimental neuroinflammation and multiple sclerosis.
das Neves SP; Sousa JC; Sousa N; Cerqueira JJ; Marques F
Glia; 2021 Jun; 69(6):1341-1368. PubMed ID: 33247866
[TBL] [Abstract][Full Text] [Related]
17. Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis.
LoPresti P
Front Neurol; 2018; 9():973. PubMed ID: 30542317
[TBL] [Abstract][Full Text] [Related]
18. Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response.
Cassiani-Ingoni R; Muraro PA; Magnus T; Reichert-Scrivner S; Schmidt J; Huh J; Quandt JA; Bratincsak A; Shahar T; Eusebi F; Sherman LS; Mattson MP; Martin R; Rao MS
J Neuropathol Exp Neurol; 2007 Jul; 66(7):637-49. PubMed ID: 17620989
[TBL] [Abstract][Full Text] [Related]
19. Role of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms.
Huseby ES; Kamimura D; Arima Y; Parello CS; Sasaki K; Murakami M
Front Cell Neurosci; 2015; 9():295. PubMed ID: 26300731
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
